Top

Published in:

01-08-1998

Skin tumor risk among atomic-bomb survivors in Japan

Authors: Elaine Ron, Dale L. Preston, Kiyohiko Mabuchi, Shoji Tokuoka, Masao Kishikawa, Masachika Iseki, Toshihiro Kobuke, Masayoshi Tokunaga

Published in: Cancer Causes & Control | Issue 4/1998

Title: Skin tumor risk among atomic-bomb survivors in Japan
Authors: Elaine Ron
Dale L. Preston
Kiyohiko Mabuchi
Shoji Tokuoka
Masao Kishikawa
Masachika Iseki
Toshihiro Kobuke
Masayoshi Tokunaga
Publication date: 01-08-1998
Publisher: Kluwer Academic Publishers
Published in: Cancer Causes & Control / Issue 4/1998
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1023/A:1008867617415

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/1998

Serum concentrations of organochlorine compounds and endometrial cancer risk (United States)

Instructions for Authors

Risk of colorectal cancer in relatives of patients with inflammatory bowel disease (Denmark)

Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States)

Diet and risk of colon cancer in a large prospective study of older women: an analysis stratified on family history (Iowa, United States)

Diabetes mellitus and pancreaticcancer mortality in a prospectivecohort of United States adults

Keynote webinar | Spotlight on antibody–drug conjugates in cancer